These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 20480845

  • 1. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
    Wolfort RM, Papillion PW, Turnage RH, Lillien DL, Ramaswamy MR, Zibari GB.
    Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
    [Abstract] [Full Text] [Related]

  • 2. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, Zeuzem S.
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [Abstract] [Full Text] [Related]

  • 3. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
    Wudel LJ, Delbeke D, Morris D, Rice M, Washington MK, Shyr Y, Pinson CW, Chapman WC.
    Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
    Kim HO, Kim JS, Shin YM, Ryu JS, Lee YS, Lee SG.
    J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
    [Abstract] [Full Text] [Related]

  • 5. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT, Kim JK, Kim DY, Ahn SH, Lee JD, Yun M, Rha SY, Chon CY, Han KH.
    Oncology; 2007 Dec; 72 Suppl 1():104-10. PubMed ID: 18087190
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
    Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Yi NJ, Lee KU.
    Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589
    [Abstract] [Full Text] [Related]

  • 8. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Mulé S, Chalaye J, Legou F, Tenenhaus A, Calderaro J, Galletto Pregliasco A, Laurent A, Kharrat R, Amaddeo G, Regnault H, Tacher V, Kobeiter H, Itti E, Luciani A.
    Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Refaat R, Basha MAA, Hassan MS, Hussein RS, El Sammak AA, El Sammak DAEA, Radwan MHS, Awad NM, Saad El-Din SA, Elkholy E, Ibrahim DRD, Saleh SA, Montasser IF, Said H.
    Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
    [Abstract] [Full Text] [Related]

  • 14. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW, Kim JH, Kim SK, Kang KW, Park KW, Choi JI, Lee WJ, Kim CM, Nam BH.
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [Abstract] [Full Text] [Related]

  • 15. Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography.
    Verhoef C, Valkema R, de Man RA, Krenning EP, Yzermans JN.
    Liver; 2002 Feb; 22(1):51-6. PubMed ID: 11906619
    [Abstract] [Full Text] [Related]

  • 16. F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
    Wu HB, Wang QS, Li BY, Li HS, Zhou WL, Wang QY.
    Clin Nucl Med; 2011 Dec; 36(12):1092-7. PubMed ID: 22064078
    [Abstract] [Full Text] [Related]

  • 17. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
    Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Iida Y, Higuchi T, Hanaoka H, Miyakubo M, Takano A, Ishikita T, Endo K.
    Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632
    [Abstract] [Full Text] [Related]

  • 18. [18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein].
    Shang JB, Li YH, Liu FY, Zeng QL, Wang JY, He XF, Chen Y.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):697-9. PubMed ID: 15201094
    [Abstract] [Full Text] [Related]

  • 19. Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination.
    Shan Q, Chen J, Zhang T, Yan R, Wu J, Shu Y, Kang Z, He B, Zhang Z, Wang J.
    Abdom Radiol (NY); 2017 Aug; 42(8):2079-2088. PubMed ID: 28337521
    [Abstract] [Full Text] [Related]

  • 20. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S, Bhattacharjya T, Quaglia A, Dhillon AP, Burroughs AK, Patch DW, Tibballs JM, Watkinson AF, Rolles K, Davidson BR.
    Dig Surg; 2004 Aug; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.